Sector Chart Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:03 2026-08-25 pm EDT
|
5-day change | 1st Jan Change | ||
| 297.64 USD | -0.31% |
|
+6.61% | +49.21% |
| Aug. 20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| Aug. 20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 14.21B | |||||
| 51.65B | |||||
| 45.31B | - | - | - | - | - |
| 42.7B | |||||
| 42.79B | |||||
| 32.87B |
Select your edition
All financial news and data tailored to specific country editions
